Johnson Investment Counsel Inc. lessened its holdings in Novo Nordisk A/S (NYSE:NVO – Free Report) by 9.9% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,868 shares of the company’s sto…